← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1194)
- Neuropathology-specific language features in primary progressive aphasia. (2026/07/01) ♡
- PBMC circRNA Profiles Distinguish Atypical From Idiopathic Parkinsonism and Track Clinical Severity Across Syndromes. (2026/07/01) ♡
- Prevalent versus incident progressive supranuclear palsy: An analysis of the frequencies of neuropathological and clinical features at U.S. Alzheimer's Disease Research Centers indicate a relatively common tauopathy of aging. (2026/07/01) ♡
- Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank. (2026/07/01) ♡
- Cerebrovascular Single-Nucleus RNA-Seq Reveals Heat Shock Activation and Vascular Remodeling in Alzheimer's Disease and Primary Tauopathies. (2026/06/28) ♡
- Nuclear Speckle Protein SRRM2 Co-localized with Pathological Tau (pTauS396) in Neuronal and Glial Cells in Progressive Supranuclear Palsy. (2026/06/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of SUMOylation in regulating proteins that drive neuronal disease progression. (2026/06/26) ♡
- Diagnostic delay and onset-anchored clinical milestones in progressive supranuclear palsy: a japanese single-center retrospective cohort study. (2026/06/24) ♡
- Locus coeruleus-norepinephrine system dysfunction: A new concept in cognitive aging and neurodegenerative diseases. (2026/06/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Functional recovery strategies in progressive supranuclear palsy with cerebellar predominance. (2026/06/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. FDG PET in Movement Disorders and Parkinsonian Syndromes. (2026/06/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies. (2026/06/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Biomarkers stewardship in parkinsonism: integrating alpha-synuclein seed amplification assays and neurofilament light chain into diagnostic pathways and patient communication. (2026/06/15) ♡
- Tau profiling of brain extracellular vesicles reveals PHF6 peptide as core for pathological tau seeding in Alzheimer's disease. (2026/06/15) ♡
- Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study. (2026/06/14) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Generation of an induced pluripotent stem cell line (NIMHi032-A) from a progressive supranuclear palsy-Richardson's syndrome patient of Indian ethnicity. (2026/06/14) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple System Atrophy-Cerebellar Variant With Absence of Parkinsonian Motor Features. (2026/06/14) ♡
- High Evans Index in progressive supranuclear palsy may mimic normal pressure hydrocephalus: a retrospective cross-sectional study. (2026/06/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. From Neonatal Cholestasis to Progressive Neurological Impairment: A Case of Niemann-Pick Disease Type C. (2026/06/12) ♡
- Development of an Interpretable Deep Learning-Based Segmentation Algorithm for Automated Assessment of Oral Diadochokinesis in Progressive Neurological Diseases. (2026/06/10) ♡
- The degenerome-a novel streamline-wise approach for white matter integrity in neurodegeneration. (2026/06/10) ♡
- Correction to: Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. (2026/06/02) ♡
- Challenges in the diagnosis and management of functional movement disorders in a developing nation: insights from the Philippines. (2026/06/02) ♡
- Neuronal-specific antibody in patients with multiple system atrophy and progressive supranuclear palsy. (2026/06/01) ♡
- Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Updates of nuclear medicine imaging in neurodegenerative disorders. (2026/06/01) ♡
- A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism. (2026/06/01) ♡
- Syndrome-specific vulnerability of neuronal and glial 4-repeat frontotemporal lobar degeneration-tau. (2026/06/01) ♡
- Disease-Specific Metabolic Patterns in Progressive Supranuclear Palsy with Richardson's Syndrome and Variants: A Longitudinal Study. (2026/06/01) ♡
- Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy. (2026/06/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Planimetric and Linear MRI Markers for Progressive Supranuclear Palsy Classification: A Large Multicohort International Study. (2026/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of DaT-SPECT Imaging in the Evaluation of Progressive Supranuclear Palsy. (2026/06/01) ♡
- It Takes a Village: Patient Satisfaction in a Specialized Atypical Parkinsonism Interdisciplinary Clinic. (2026/05/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Supranuclear Palsy Unmasked After Post-COVID-19 Functional Decline in an Elderly Patient: A Diagnostic Challenge. (2026/05/27) ♡
- Unraveling sleep dysfunction in progressive supranuclear palsy: a pilot study on the role of periodic limb movements in sleep and insomnia. (2026/05/25) ♡
- Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR-PSP). (2026/05/24) ♡
- Three-dimensional kinematic gait signatures of idiopathic normal pressure hydrocephalus: a biomechanical framework toward objective diagnosis. (2026/05/22) ♡
- Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations. (2026/05/22) ♡
- Unilateral inferior olivary hypertrophy in a patient with primary progressive apraxia of speech. (2026/05/21) ♡
- Safety, Feasibility, and Efficacy of Immersive Virtual Reality Training With a Body Weight Support System for Patients With Extrapyramidal Disorders: A Pilot Case Series Study. (2026/05/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges. (2026/05/19) ♡
- Peripheral Immunological Signatures of Parkinsonism: Insights from the Caribbean vs. North America. (2026/05/16) ♡
- Screening speech disorders in progressive neurological diseases via long-term average spectrum. (2026/05/14) ♡
- Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states. (2026/05/14) ♡
- Metagenomic profiling of ocular surface microbiome alterations in patients with progressive supranuclear palsy-Richardson's syndrome. (2026/05/14) ♡
- Comparing the value of dynamic versus static image-based tests of emotion recognition in neurodegenerative disease. (2026/05/13) ♡
- Cell Cycle Dysfunction and Metabolic Alterations Consistent With Pathological Tau in Progressive Supranuclear Palsy Derived Fibroblasts. (2026/05/12) ♡
- Swallowing-related quality of life in progressive supranuclear palsy. (2026/05/06) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.